If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,599.00
Bid: 4,598.00
Ask: 4,599.00
Change: 2.00 (0.04%)
Spread: 1.00 (0.022%)
Open: 4,585.00
High: 4,615.00
Low: 4,577.00
Prev. Close: 4,597.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

11 Mar 2024 07:00

RNS Number : 2355G
Reckitt Benckiser Group PLC
11 March 2024
 

Transaction in own shares

 

Reckitt Benckiser Group plc (the "Company") announces today it has purchased the following number of its ordinary shares of 10 pence each ("shares") from Merrill Lynch International in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2023 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 19 December 2023, as announced on 20 December 2023. The repurchased shares will be held in treasury.

 

Ordinary Shares

 

Date of purchase:

8 March 2024

Aggregate number of ordinary shares purchased:

166,897

Highest price paid per share (pence):

5,182.00

Lowest price paid per share (pence):

5,100.00

Volume weighted average price paid per share (pence):

5,149.24

 

Following settlement of the above transaction, the Company will hold 26,320,346 of its ordinary shares in treasury and have 710,214,833 ordinary shares in issue (excluding treasury shares).

 

Therefore, the total number of voting rights in the Company will be 710,214,833 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a full breakdown of the individual trades made by the Broker on behalf of the Company is detailed below: 

 

http://www.rns-pdf.londonstockexchange.com/rns/2355G_1-2024-3-8.pdf

 

 

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDVLFBZXLZBBE
Date   Source Headline
5th Aug 202212:07 pmRNSDirector Declaration
1st Aug 20224:07 pmRNSTotal Voting Rights
27th Jul 20227:00 amRNSHalf-year Results
19th Jul 20229:41 amRNSDirector Declaration
1st Jul 20221:34 pmRNSTotal Voting Rights
13th Jun 202211:45 amRNSDirector/PDMR Shareholding
1st Jun 202212:37 pmRNSTotal Voting Rights
23rd May 20225:28 pmRNSDirector/PDMR Shareholding
20th May 20225:30 pmRNSResult of AGM
3rd May 202212:54 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNS1st Quarter Results
27th Apr 20224:29 pmRNSNotice of AGM
14th Apr 202212:26 pmRNSAnnual Financial Report
1st Apr 20221:57 pmRNSTotal Voting Rights
22nd Mar 202212:18 pmRNSDirector/PDMR Shareholding
1st Mar 20223:39 pmRNSTotal Voting Rights
17th Feb 20227:00 amRNSReckitt FY 2021 Results
1st Feb 202210:32 amRNSTotal Voting Rights
17th Jan 20229:00 amRNSDirectorate Change
4th Jan 202211:21 amRNSTotal Voting Rights
24th Dec 20217:00 amRNSProposed Sale of E45 to Karo Pharma
1st Dec 202111:22 amRNSTotal Voting Rights
1st Nov 202111:47 amRNSTotal Voting Rights
26th Oct 202110:01 amRNSDirectorate Change
26th Oct 20217:00 amRNS3rd Quarter Results
4th Oct 20219:35 amRNSDirectorate Change
1st Oct 202111:15 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSTrading Update & Launch of Investor Seminar Series
16th Sep 20211:20 pmRNSDirector/PDMR Shareholding
9th Sep 20219:24 amRNSClosing sale of IFCN China business to Primavera
1st Sep 202111:08 amRNSTotal Voting Rights
31st Aug 20214:00 pmRNSDirector/PDMR Shareholding
4th Aug 202110:30 amRNSDirector/PDMR Shareholding
3rd Aug 20211:30 pmRNSDirector/PDMR Shareholding
2nd Aug 202112:50 pmRNSTotal Voting Rights
30th Jul 202110:57 amRNSDirector Declaration
29th Jul 20213:30 pmRNSDirector/PDMR Shareholding
28th Jul 20214:00 pmRNSDirector/PDMR Shareholding
28th Jul 202110:00 amRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSHalf-Year Report
1st Jul 202111:23 amRNSTotal Voting Rights
25th Jun 20212:45 pmRNSDirector Declaration
23rd Jun 20214:25 pmRNSDirector/PDMR Shareholding
17th Jun 202111:31 amRNSDirector/PDMR Shareholding
7th Jun 20217:00 amRNSReckitt to sell IFCN China for US $2.2billion
1st Jun 20212:20 pmRNSDirector/PDMR Shareholding
1st Jun 202112:43 pmRNSTotal Voting Rights
28th May 20216:09 pmRNSResult of AGM
4th May 202111:58 amRNSTotal Voting Rights
28th Apr 20217:00 amRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.